ENTX
Entera Bio Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$3.00
+1.69%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+157.5%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Aug 7, 2026 | Germano Geno J · director | A-Award | 50,000 | $1.37 |
| Aug 7, 2026 | Germano Geno J · director | A-Award | 43,014 | $1.37 |
| Aug 7, 2026 | Malca Yonatan · director | A-Award | 22,815 | $0.00 |
| Aug 7, 2026 | Taitel Haya · director | A-Award | 20,790 | $0.00 |
| Aug 7, 2026 | Ellis Sean · director | A-Award | 20,034 | $0.00 |
| Aug 7, 2026 | Ellis Sean · director | A-Award | 40,000 | $1.37 |
| Aug 7, 2026 | Yaacov-Garbeli Dana · officer: Chief Financial Officer | A-Award | 140,000 | $1.37 |
| Aug 7, 2026 | Galitzer Hillel · officer: Chief Operating Officer | A-Award | 200,000 | $1.37 |
| Aug 7, 2026 | Burshtein Gregory · officer: Chief of R&D | A-Award | 180,000 | $1.37 |
| Aug 7, 2026 | Toledano Miranda Jayne · director, officer: Chief Executive Officer | A-Award | 500,000 | $1.37 |
| Aug 7, 2026 | Toledano Miranda Jayne · director, officer: Chief Executive Officer | A-Award | 200,000 | $2.81 |
| Aug 7, 2026 | Germano Geno J · director | A-Award | 25,014 | $0.00 |
| Jul 16, 2026 | Toledano Miranda Jayne · director, officer: Chief Executive Officer | A-Award | 72,993 | $0.00 |
| Jul 16, 2026 | Toledano Miranda Jayne · director, officer: Chief Executive Officer | A-Award | 347,567 | $0.00 |
| May 8, 2026 | Galitzer Hillel · officer: Chief Operating Officer | A-Award | 72,993 | $0.00 |
| May 8, 2026 | Burshtein Gregory · officer: Chief of R&D | A-Award | 87,591 | $0.00 |
| May 8, 2026 | Yaacov-Garbeli Dana · officer: Chief Financial Officer | A-Award | 58,394 | $0.00 |
| Mar 11, 2026 | Germano Geno J · director | Purchase | 20,000 | $1.30 |
| Mar 9, 2026 | Ellis Sean · director | Purchase | 10,000 | $1.23 |
| Feb 11, 2026 | Germano Geno J · director | Purchase | 20,000 | $1.49 |
| Feb 11, 2026 | Ellis Sean · director | Purchase | 18,000 | $1.24 |
| Feb 11, 2026 | Taitel Haya · director | Purchase | 7,500 | $1.48 |
| Jan 2, 2026 | OSTROV GERALD M · director | A-Award | 28,721 | $0.00 |
| Jan 2, 2026 | Taitel Haya · director | A-Award | 26,329 | $0.00 |
| Jan 2, 2026 | LIEBERMAN GERALD M · director | A-Award | 33,505 | $1.94 |
| Jan 2, 2026 | LIEBERMAN GERALD M · director | A-Award | 38,294 | $0.00 |
| Jan 2, 2026 | Malca Yonatan · director | A-Award | 33,505 | $1.94 |
| Jan 2, 2026 | Malca Yonatan · director | A-Award | 30,157 | $0.00 |
| Jan 2, 2026 | Taitel Haya · director | A-Award | 33,505 | $1.94 |
| Jan 2, 2026 | Ellis Sean · director | A-Award | 33,505 | $1.94 |
Institutional positioning
13F filings over the trailing two quarters
New 9Increased 5Reduced 8Sold out 26
| Filer | Action | Shares | Filed |
|---|---|---|---|
| KNOLL CAPITAL MANAGEMENT, LLC | Unchanged | 5,881,879 | May 15, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | Increased | 473,442 | May 14, 2026 |
| PARKMAN HEALTHCARE PARTNERS LLC | Increased | 288,670 | May 15, 2026 |
| CITADEL ADVISORS LLC | Increased | 245,577 | May 15, 2026 |
| Seven Fleet Capital Management LP | Increased | 205,542 | Jun 4, 2026 |
| MARSHALL WACE, LLP | Reduced | 195,780 | May 15, 2026 |
| NORTHERN TRUST CORP | Reduced | 146,854 | May 14, 2026 |
| XTX TOPCO LTD | New Position | 131,622 | May 15, 2026 |
| SCHONFELD STRATEGIC ADVISORS LLC | Reduced | 55,223 | May 15, 2026 |
| CITADEL ADVISORS LLC | Reduced | 48,904 | Sep 2, 2026 |
| SIGNATURE ESTATE & INVESTMENT ADVISORS LLC | Unchanged | 47,328 | Apr 15, 2026 |
| HIGHTOWER ADVISORS, LLC | Reduced | 36,830 | May 5, 2026 |
| JANE STREET GROUP, LLC | Reduced | 32,915 | May 12, 2026 |
| DIADEMA PARTNERS LP | New Position | 23,260 | May 15, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Unchanged | 21,136 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 7, 2026